Postpartum recovery is a crucial yet needed aspect of maternal health.
Results of ACCURACY: A phase 2 trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback